Test Code TNI Troponin I
Additional Codes
Cerner |
NextGen |
Troponin I |
Troponin I |
Methodology
(Vitros) Immunometric immunoassay, Chemiluminescent
Patient Preparation
None
Collection Instructions
- Standard phlebotomy practices.
- Troponin testing is normally performed in the following order
- 0 hr (Baseline)
- 3 hr (delta calculated)
- 6 hr (delta calculated)
Specimen Requirements
Container |
|
||||||||||||
Stability |
|
||||||||||||
Rejection Criteria |
Gross Hemolysis Turbid Specimens |
Result Reporting and Reference Values
Reported in ng/mL
Negative |
0.00-0.034 |
Borderline |
0.035-0.119 |
Consistent with MI (Critical Value) |
≥ 0.120 |
Reflex Testing
None
Limitations
- Ortho reports a bias with the following:
- Biotin can cause a negative bias.
- Ortho reports no significant effect with the following:
- Bilirubin up to 20 mg/dL
Useful For
Troponin I (TNI) is a protein normally found in muscle tissue that, in conjunction with Troponin T and Troponin C, regulates the calcium dependent interaction of actin and myosin. Clinical studies have demonstrated that cardiac Troponin I (cTnI) is detectable in the bloodstream 4-6 hours after an acute myocardial infarction and remains elevated several days thereafter. Thus, cTnI elevation covers the diagnostic windows of both CK-MB and LDH. Further studies have indicated that cTnI has a higher clinical specificity for myocardial injury than does CK-MB. Because of its cardiac specificity and sensitivity, cTnI has been used as a reliable marker in evaluating patients with unstable angina and non-ST segment elevation acute coronary syndrome.
Other conditions resulting in myocardial cell damage can contribute to elevated cTnI levels; these conditions include sepsis, congestive heart failure, hypertension with left ventricular hypertrophy, hemodynamic compromise, and myocarditis, mechanical injury including cardiac surgery, defibrillation and cardiac toxins such as anthracyclines.